Literature DB >> 19911250

The first Italian family with tibial muscular dystrophy caused by a novel titin mutation.

Marzia Pollazzon1, Tiina Suominen, Sini Penttilä, Alessandro Malandrini, Maria Alessandra Carluccio, Mauro Mondelli, Annabella Marozza, Antonio Federico, Alessandra Renieri, Peter Hackman, Maria Teresa Dotti, Bjarne Udd.   

Abstract

Tibial muscular dystrophy (TMD) or Udd myopathy is an autosomal dominant distal myopathy with late onset, at first described in the Finnish population. We report here the first Italian cases of TTN mutated titinopathy. The proband, a 60 year-old female, had the first muscular signs at the age of 59 years, with difficulty in walking and right foot drop. Muscle imaging showed selective fatty degenerative change in the anterior compartment of leg muscles. Her 67 year-old brother, started to show muscle weakness, pain at lower limbs and hypertrophy of calf muscles at the age of 66 years. Their mother began to show foot drop and impaired walking from the age of 60 years. Other relatives are reported to be affected in a similar way. Because the phenotype appeared compatible with TMD, we analyzed the TTN gene in the DNA of the proband and we identified a heterozygous mutation 293326A>C. This mutation is also present in the brother and in the other affected individuals of the same family. The mutation predicts a His33378Pro change located next to the previously known Belgian TMD mutation. The mutation was not found in 100 Italian control DNA samples. Then, since the introduction of a proline in the last domain of titin was previously known to cause TMD in French families, we can conclude that this missense mutation is the obvious pathogenetic mutation in the affected patients. No other disease causing mutations in the TTN gene have so far been reported in the Italian population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911250     DOI: 10.1007/s00415-009-5372-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J.

Authors:  B Udd; A Vihola; J Sarparanta; I Richard; P Hackman
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

2.  Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene.

Authors:  H Haravuori; A Vihola; V Straub; M Auranen; I Richard; S Marchand; T Voit; S Labeit; H Somer; L Peltonen; J S Beckmann; B Udd
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

3.  Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.

Authors:  Brenda Gerull; Michael Gramlich; John Atherton; Mark McNabb; Karoly Trombitás; Sabine Sasse-Klaassen; J G Seidman; Christine Seidman; Henk Granzier; Siegfried Labeit; Michael Frenneaux; Ludwig Thierfelder
Journal:  Nat Genet       Date:  2002-01-14       Impact factor: 38.330

4.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.

Authors:  M Satoh; M Takahashi; T Sakamoto; M Hiroe; F Marumo; A Kimura
Journal:  Biochem Biophys Res Commun       Date:  1999-08-27       Impact factor: 3.575

5.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

6.  The first European family with tibial muscular dystrophy outside the Finnish population.

Authors:  J de Seze; B Udd; H Haravuori; B Sablonnière; C A Maurage; J F Hurtevent; N Boutry; T Stojkovic; S Schraen; H Petit; P Vermersch
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

7.  Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).

Authors:  Peter Hackman; Sylvie Marchand; Jaakko Sarparanta; Anna Vihola; Isabelle Pénisson-Besnier; Bruno Eymard; Jose Manuel Pardal-Fernández; El-Hadi Hammouda; Isabelle Richard; Isabel Illa; Bjarne Udd
Journal:  Neuromuscul Disord       Date:  2008-10-22       Impact factor: 4.296

8.  Muscular dystrophy with separate clinical phenotypes in a large family.

Authors:  B Udd; H Kääriänen; H Somer
Journal:  Muscle Nerve       Date:  1991-11       Impact factor: 3.217

9.  Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients.

Authors:  B Udd; J Partanen; P Halonen; B Falck; L Hakamies; H Heikkilä; S Ingo; H Kalimo; H Kääriäinen; V Laulumaa
Journal:  Arch Neurol       Date:  1993-06

10.  C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.

Authors:  Virginie Carmignac; Mustafa A M Salih; Susana Quijano-Roy; Sylvie Marchand; Molham M Al Rayess; Maowia M Mukhtar; Jon A Urtizberea; Siegfried Labeit; Pascale Guicheney; France Leturcq; Mathias Gautel; Michel Fardeau; Kevin P Campbell; Isabelle Richard; Brigitte Estournet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

View more
  15 in total

1.  Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin.

Authors:  Florian Sauer; Juha Vahokoski; Young-Hwa Song; Matthias Wilmanns
Journal:  EMBO Rep       Date:  2010-05-21       Impact factor: 8.807

2.  A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population.

Authors:  Stojan Perić; Jelena Nikodinović Glumac; Ana Töpf; Dušanka Savić-Pavićević; Lauren Phillips; Katherine Johnson; Marcus Cassop-Thompson; Liwen Xu; Marta Bertoli; Monkol Lek; Daniel MacArthur; Miloš Brkušanin; Sanja Milenković; Vedrana Milić Rašić; Bojan Banko; Ružica Maksimović; Hanns Lochmüller; Vidosava Rakočević Stojanović; Volker Straub
Journal:  Eur J Hum Genet       Date:  2017-03-15       Impact factor: 4.246

3.  Biophysical characterization of naturally occurring titin M10 mutations.

Authors:  Michael W Rudloff; Alec N Woosley; Nathan T Wright
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

4.  Titin and obscurin: giants holding hands and discovery of a new Ig domain subset.

Authors:  Guy M Benian; Olga Mayans
Journal:  J Mol Biol       Date:  2014-12-31       Impact factor: 5.469

5.  Neuromuscular disorders and 2010: recent advances.

Authors:  Anna Sarkozy; Hanns Lochmüller
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

6.  Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.

Authors:  Stefano Pernigo; Atsushi Fukuzawa; Morten Bertz; Mark Holt; Matthias Rief; Roberto A Steiner; Mathias Gautel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 7.  Distal myopathies.

Authors:  Bjarne Udd
Journal:  Curr Neurol Neurosci Rep       Date:  2014-03       Impact factor: 5.081

Review 8.  The sarcomeric M-region: a molecular command center for diverse cellular processes.

Authors:  Li-Yen R Hu; Maegen A Ackermann; Aikaterini Kontrogianni-Konstantopoulos
Journal:  Biomed Res Int       Date:  2015-04-15       Impact factor: 3.411

9.  Gene expression profiling in tibial muscular dystrophy reveals unfolded protein response and altered autophagy.

Authors:  Mark Screen; Olayinka Raheem; Jeanette Holmlund-Hampf; Per Harald Jonson; Sanna Huovinen; Peter Hackman; Bjarne Udd
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

10.  Recessive TTN truncating mutations define novel forms of core myopathy with heart disease.

Authors:  Claire Chauveau; Carsten G Bonnemann; Cedric Julien; Ay Lin Kho; Harold Marks; Beril Talim; Philippe Maury; Marie Christine Arne-Bes; Emmanuelle Uro-Coste; Alexander Alexandrovich; Anna Vihola; Sebastian Schafer; Beth Kaufmann; Livija Medne; Norbert Hübner; A Reghan Foley; Mariarita Santi; Bjarne Udd; Haluk Topaloglu; Steven A Moore; Michael Gotthardt; Mark E Samuels; Mathias Gautel; Ana Ferreiro
Journal:  Hum Mol Genet       Date:  2013-10-08       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.